Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
5.57
-0.08 (-1.50%)
Jun 29, 2026, 12:02 PM EDT - Market open
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $1.94 billion as of June 29, 2026. Its market cap has increased by 214.63% in one year.
Market Cap
1.94B
Enterprise Value
1.65B
1-Year Change
214.63%
Ranking
Category
Stock Price
$5.57
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $1.94B, an increase of 1,010.59%. That is a compound annual growth rate of 50.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 1.94B | -36.92% |
| Dec 31, 2025 | 3.07B | 243.11% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADMA Biologics | 2.03B |
| Taysha Gene Therapies | 2.03B |
| Zai Lab | 2.02B |
| Stoke Therapeutics | 1.99B |
| Viridian Therapeutics | 1.98B |
| AtaiBeckley | 1.95B |
| GH Research | 1.94B |
| Lakefront Biotherapeutics NV | 1.93B |